Ionis Pharmaceuticals IONS Other Working Capital
Other Working Capital at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInContractWithCustomerAsset.
The official record: Ionis Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's other working capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's other working capital?
- Ionis Pharmaceuticals (IONS) reported other working capital of $7.63M in Q1 2026.
- How has Ionis Pharmaceuticals's other working capital changed year-over-year?
- Ionis Pharmaceuticals's other working capital increased by 114.5% year-over-year, from -$52.48M to $7.63M.
- What does other working capital mean?
- The net change in various minor operating assets and liabilities.
- How do you interpret other working capital?
- Large fluctuations can indicate volatility in timing of payments or receipts, requiring further investigation into operational efficiency.
- How does other working capital compare across companies?
- Standard line item in the cash flow statement for all operating companies.